188 related articles for article (PubMed ID: 23510770)
1. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():viii-ix. PubMed ID: 23510770
[No Abstract] [Full Text] [Related]
2. Executive summary.
Vaccine; 2012 Nov; 30 Suppl 4():xi. PubMed ID: 23510772
[No Abstract] [Full Text] [Related]
3. The Global Alliance for Vaccines and Immunization (GAVI).
Schwalbe N
Vaccine; 2012 Nov; 30 Suppl 4():x. PubMed ID: 23510771
[No Abstract] [Full Text] [Related]
4. The path to eliminate cervical cancer in the world and the challenges of professional education. Preface.
Bosch FX
Vaccine; 2012 Nov; 30 Suppl 5():xi-xii. PubMed ID: 23199971
[No Abstract] [Full Text] [Related]
5. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
[No Abstract] [Full Text] [Related]
6. WHO consultation on human papillomavirus vaccines.
WHO
Wkly Epidemiol Rec; 2005 Sep; 80(35):299-302. PubMed ID: 16180643
[No Abstract] [Full Text] [Related]
7. The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.
Vaccine; 2012 Nov; 30 Suppl 4():xii. PubMed ID: 23510773
[No Abstract] [Full Text] [Related]
8. Global elimination of cervical cancer is achievable-with commitment.
The Lancet Oncology
Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
[No Abstract] [Full Text] [Related]
9. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX
Vaccine; 2013 Dec; 31 Suppl 5():xi-xii. PubMed ID: 24331752
[No Abstract] [Full Text] [Related]
10. The path to eliminate cervical cancer in the world and the challenges of professional education.
Bosch FX;
Vaccine; 2013 Dec; 31 Suppl 7():xi-xii. PubMed ID: 24332302
[No Abstract] [Full Text] [Related]
11. Cervical cancer: who's at risk?
McCormish E
Nurs Womens Health; 2011 Dec; 15(6):476-83. PubMed ID: 22900688
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
13. HPV and cervical cancer in the 2007 report.
WHO/ICO Information Centre on HPV and Cervical Cancer
Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
[No Abstract] [Full Text] [Related]
14. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
Wheeler CM
Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
[No Abstract] [Full Text] [Related]
15. World Health Organization call for action to eliminate cervical cancer globally.
Gultekin M; Ramirez PT; Broutet N; Hutubessy R
Int J Gynecol Cancer; 2020 Apr; 30(4):426-427. PubMed ID: 32122950
[No Abstract] [Full Text] [Related]
16. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
17. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
18. Controlling cervical cancer.
Bonati M; Garattini S
Pharmacoeconomics; 2009; 27(2):91-3. PubMed ID: 19254043
[No Abstract] [Full Text] [Related]
19. Human papillomavirus.
Brody H
Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432
[No Abstract] [Full Text] [Related]
20. [HPV vaccination and screening to eliminate cervical cancer. FIGO report].
Ginekol Pol; 2008 Jun; 79(6):445-6. PubMed ID: 18652135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
